This company seems to have been delisted
Reason: Merged with Opus Genetics
Last recorded trade on: December 26, 2024
Source: https://finance.yahoo.com/news/ocuphire-pharma-merges-opus-genetics-213102859.html
Reason: Merged with Opus Genetics
Last recorded trade on: December 26, 2024
Source: https://finance.yahoo.com/news/ocuphire-pharma-merges-opus-genetics-213102859.html
Ocuphire Pharma
OCUP
$1.17
Share price
-12.03%
Change (1 day)
-30.36%
Change (1 year)
Categories
Ocuphire Pharma (OCUP) - Total debt
Total debt on the balance sheet as of March 2022 : $0.21 Million USD
According to Ocuphire Pharma's latest financial reports the company's total debt is $0.21 Million USD. A company’s total debt is the sum of all current and non-current debts.
Ocuphire Pharma - Total debt on balance sheet (from 2021 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2021-12-31 | $0.53 M | |
| 2019-12-31 | $5.66 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |
 OPKO Health
OPK | $0.49 B | 229,150.70% | 🇺🇸 USA |